Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Clinicopathological characteristics of patients and MTFR2 expression in ESCC

Characteristics No. of cases (%)
Sex
Female 6 (5.22)
Male 109 (94.78)
Age (yr)
> 60 56 (48.70)
≤ 60 59 (51.30)
Clinical stage
I/II 79 (68.70)
III/IV 36 (31.30)
T stage
1 20 (17.39)
2 36 (31.30)
3 40 (34.78)
4 19 (16.52)
N stage
0 76 (66.09)
1 33 (28.70)
2 6 (5.22)
M stage
0 110 (95.65)
1 5 (4.35)
Vital status
Alive 53 (46.09)
Dead 62 (53.91)
Histological differentiation
High 22 (19.13)
Moderate 67 (58.26)
Low 26 (22.61)
Expression of MTFR2
Low 77 (67.00)
High 38 (33.00)
J Cancer Prev 2021;26:250~257 https://doi.org/10.15430/JCP.2021.26.4.250
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd